1. FTC Secures Landmark Settlement with Express Scripts to Lower Drug Costs for American Patients. United States Federal ...

Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing.

The FTC's landmark settlement forces Express Scripts PBM to overhaul practices, banning the preference of expensive insulin ...

The settlement comes after years of meetings between NCPA and FTC staff, during which NCPA’s legal team educated government lawyers on the many egregious PBM practices that squash competition, reduce ...

Cigna Corp's Express Scripts settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated ...

The agreement includes sweeping changes for Cigna’s PBM, including no longer preferring expensive drugs over cheaper equivalents on standard formularies and reshoring its controversial rebate ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. The state of Michigan is suing two of the nation’s largest ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

FTC's July 2024 report makes unsubstantiated, false and biased claims about the PBM industry; fails to take into account the value that PBMs deliver to consumers and patients Information about Express ...

Amid increased scrutiny from policymakers, the pharmacy benefit manager (PBM) industry is now looking to strike back through legal channels. Express Scripts, one of the biggest PBMs in the U.S., ...

The lawsuit alleges that in December 2019, Express Scripts and Prime Therapeutics entered into an agreement for the latter to adopt Express Scripts' lower reimbursement rates in exchange for accessing ...

Canadian officials have obtained a court order that requires Express Scripts to produce documents in connection with an investigation into whether the pharmacy benefits manager violated antitrust laws ...